Containment Generic Drugs Generic Pharmaceutical 
The Pharma Data
MARCH 15, 2022
Agency Supports Development of Complex Generic Drug-Device Combination Product to Improve Competition and Access to More Affordable Medicines. This complex generic drug-device combination product, which is a metered-dose inhaler, should not be used to treat acute asthma attacks. Today, the U.S.
XTalks
AUGUST 2, 2023
Comirnaty was first approved by the US Food and Drug Administration (FDA) in August 2021 for individuals over the age of 16. It contains the antiviral medications nirmatrelvir and ritonavir. In 2022, Biktarvy generated $10.39 In 2022, Xgeva generated $2.01 Together, these two medications generated a total of €1.70
Expert insights. Personalized for you.
52 
Let's personalize your content